KATELYN BEINBURG: Open Payments
NPI 1255906079 · LOCUST GROVE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 43 payments from 12 companies in 2025. Trend: 2023 $513 · 2024 $915 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $219 |
| Madrigal Pharmaceuticals | 4 | $107 |
| Phathom Pharmaceuticals, Inc. | 6 | $86 |
| Ardelyx, Inc. | 4 | $77 |
| PFIZER INC. | 4 | $74 |
| QOL Medical, LLC | 3 | $71 |
| Mauna Kea Technologies, Inc. | 3 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Medtronic, Inc. | 1 | $29 |
Products named: REZDIFFRA, LINZESS, VOQUEZNA, IBSRELA, VELSIPITY, Sucraid, MAVYRET, ZENPEP.
Industry payments across GA — which companies pay providers there.
